Comparative analysis of clinical and epidemiological characteristics of patients with CAP (community-acquired pneumonia) treated as inpatients and outpatients

S. Krstic, M. Percinkovski, M. Danilovic, S. Popevic (Belgrade, Serbia And Montenegro)

Source: Annual Congress 2006 - Miscellaneous respiratory infections II
Session: Miscellaneous respiratory infections II
Session type: E-Posters in free access
Number: 134
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Krstic, M. Percinkovski, M. Danilovic, S. Popevic (Belgrade, Serbia And Montenegro). Comparative analysis of clinical and epidemiological characteristics of patients with CAP (community-acquired pneumonia) treated as inpatients and outpatients. Eur Respir J 2006; 28: Suppl. 50, 134

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Retrospective analysis of clinical data of 315 hospitalized patients with community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 415s
Year: 2004

Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006

The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Clinical stability in patients with community- acquired pneumonia (CAP)
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010

Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Biological markers in hospitalised patients with community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Etiologic and clinical characteristic of hospitalized patients with CAP
Source: Eur Respir J 2006; 28: Suppl. 50, 4s
Year: 2006

Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2013; 42: 742-749
Year: 2013